Champions Oncology (CSBR) Misses Q4 EPS by 9c
Tweet
Share
E-mailGet Alerts CSBR Hot Sheet
Price: $5.07 -0.2%
Financial Fact:
Loss from operations: -2.52M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Loss from operations: -2.52M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Champions Oncology (NASDAQ: CSBR) reported Q4 EPS of ($0.17), $0.09 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $13.1 million versus the consensus estimate of $12.84 million.
For earnings history and earnings-related data on Champions Oncology (CSBR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
- Reading (RDI) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
